Q4 2022 Holdings
Filed 2023-02-14 | 79 holdings | $355.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Phasebio Pharmaceuticals Inc | COM | 717224109 | $9.7K | 321,856 | 0.0% |
| Reunion Neuroscience Inc | COM | 76134G103 | $42.9K | 47,679 | 0.0% |
| Compugen LTD(CGEN) | ORD | M25722105 | $146.9K | 205,202 | 0.0% |
| Lineage Cell Therapeutics in(LCTX) | COM | 53566P109 | $163.8K | 140,000 | 0.0% |
| Black Diamond Therapeutics I(BDTX) | COM | 09203E105 | $175.5K | 97,500 | 0.0% |
| Acrivon Therapeutics Inc(ACRV) | COMMON STOCK | 004890109 | $180.3K | 15,648 | 0.1% |
| Spero Therapeutics Inc(SPRO) | COM | 84833T103 | $216.3K | 125,000 | 0.1% |
| Scynexis Inc(SCYX) | COM NEW | 811292200 | $239.1K | 153,269 | 0.1% |
| Nextcure Inc | COM | 65343E108 | $264.7K | 187,696 | 0.1% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $267.6K | 39,879 | 0.1% |
| Biomea Fusion Inc(BMEA) | COM | 09077A106 | $291.9K | 34,625 | 0.1% |
| Inogen Inc(INGN) | COM | 45780L104 | $295.7K | 15,000 | 0.1% |
| Medicenna Therapeutics Corp(MDNAF) | COM | 58490H107 | $302.3K | 660,000 | 0.1% |
| Ikena Oncology Inc | COM | 45175G108 | $325.9K | 122,517 | 0.1% |
| Theseus Pharmaceuticals Inc | COM | 88369M101 | $407.7K | 81,859 | 0.1% |
| Kinnate Biopharma Inc | COM | 49705R105 | $433.1K | 71,008 | 0.1% |
| Masimo Corp(MASI) | COM | 574795100 | $443.9K | 3,000 | 0.1% |
| Adaptimmune Therapeutics PLC(ADAPY) | SPONDS ADR | 00653A107 | $512.6K | 351,064 | 0.1% |
| Brainsway LTD(BWAY) | SPONSORED ADS | 10501L106 | $543.4K | 220,000 | 0.2% |
| Cincor Pharma Inc | COM | 17240Y109 | $589.9K | 48,000 | 0.2% |
| Surface Oncology Inc | COM | 86877M209 | $642.1K | 783,000 | 0.2% |
| Karyopharm Therapeutics Inc(KPTIEUR) | COM | 48576U106 | $655.1K | 192,678 | 0.2% |
| Regulus Therapeutics Inc(RGLS) | COM | 75915K309 | $761.1K | 555,555 | 0.2% |
| Pardes Biosciences Inc | COM | 69945Q105 | $810.2K | 479,386 | 0.2% |
| Mereo Biopharma Group PLC(MREO) | SPON ADS | 589492107 | $822.4K | 1,096,513 | 0.2% |
| Affimed N V | COM | N01045108 | $851.0K | 686,282 | 0.2% |
| Genfit S A | ADS | 372279109 | $868.8K | 197,940 | 0.2% |
| Syros Pharmaceuticals Inc(SYRS) | COM NEW | 87184Q206 | $954.5K | 265,878 | 0.3% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $1.1M | 171,059 | 0.3% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $1.6M | 264,237 | 0.4% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $1.6M | 33,000 | 0.4% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $1.8M | 144,784 | 0.5% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $1.9M | 98,560 | 0.5% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $2.0M | 473,136 | 0.6% |
| Vigil Neuroscience Inc(VIGL) | COM | 92673K108 | $2.1M | 168,846 | 0.6% |
| Neuronetics Inc(STIM) | COM | 64131A105 | $2.2M | 313,717 | 0.6% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $2.2M | 1,176,150 | 0.6% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $2.3M | 52,675 | 0.7% |
| Mersana Therapeutics Inc | COM | 59045L106 | $2.4M | 413,463 | 0.7% |
| Century Therapeutics Inc(IPSC) | COM | 15673T100 | $2.4M | 475,367 | 0.7% |
| Accuray Inc(ARAY) | COM | 004397105 | $2.6M | 1,222,358 | 0.7% |
| Mediwound LTD(MDWD) | SHS NEW | M68830112 | $2.8M | 204,082 | 0.8% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $2.9M | 251,000 | 0.8% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $2.9M | 142,217 | 0.8% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $3.0M | 602,051 | 0.9% |
| Atricure Inc(ATRC) | COM | 04963C209 | $3.2M | 72,029 | 0.9% |
| Axogen Inc(AXGN) | COM | 05463X106 | $3.3M | 332,103 | 0.9% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $3.3M | 73,600 | 0.9% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $3.6M | 122,200 | 1.0% |
| F-Star Therapeutics Inc | COM | 30315R107 | $3.6M | 576,881 | 1.0% |